ALB and hepatocellular carcinoma: CRP and albumin ratio (CAR), as a new inflammation-based prognostic score, has been demonstrated to show prognostic value in hepatocellular carcinoma (HCC), oesophageal squamous-cell carcinoma, and small-cell lung cancer [10,11].